TSCAN THERAPEUTICS, INC. Cash and Restricted Cash
TSCAN THERAPEUTICS, INC. (TCRX) had Cash and Restricted Cash of $105.19 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $105.19M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $133.09M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $157.44M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $174.54M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $105.19M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $133.09M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $157.44M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $174.54M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $174.43M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $159.14M 10-Q · filed 2026-05-06 |
| 2024-12-31 | $183.72M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $138.15M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $247.19M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $145.54M 10-Q · filed 2025-05-06 |
| 2023-12-31 | $138.39M 10-K · filed 2026-03-04 |
| 2023-09-30 | $160.22M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $213.87M 10-Q · filed 2024-08-12 |
| 2023-03-31 | $100.64M 10-Q · filed 2024-05-13 |
| 2022-12-31 | $125.06M 10-K · filed 2025-03-05 |
| 2022-09-30 | $142.34M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $130.64M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $145.87M 10-Q · filed 2023-05-10 |
| 2021-12-31 | $166.44M 10-K · filed 2024-03-06 |
| 2021-09-30 | $182.91M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $106.79M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $122.10M 10-Q · filed 2022-05-12 |
| 2020-12-31 | $35.39M 10-K · filed 2023-03-08 |
| 2020-09-30 | $44.08M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $51.21M 10-Q · filed 2021-08-19 |
| 2019-12-31 | $42.36M 10-K · filed 2022-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B |